Vellanki Avanish 4
4 · Rain Therapeutics Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-03-11$4.00/sh+14,468$57,872→ 2,837,009 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-11−14,468→ 31,832 totalExercise: $4.00Exp: 2030-11-12→ Common Stock (14,468 underlying)
Holdings
- 138,901(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This option represents a right to purchase a total of 46,300 shares of the Issuer's common stock, which vests in equal monthly installments through November 13, 2024, subject to the Reporting Person's continued service to the Issuer.